Stetten - The Switzerland-based Exentis Group AG is broadening its Business Development function. Going forward, a Chief Commercial Officer and a Chief Product Officer will be responsible for overseeing this function at board level. To this end, Michael Leitner is leaving Virgin Pulse to join Exentis.

Stetten AG - Exentis Group AG has achieved an overall score far higher than the standard in an esg2go sustainability analysis. The company scored particularly well in the area of Energy & Waste. Its 3D technology significantly minimizes volumes of resources and waste.

Stetten - Exentis' 3D technology can further accelerate the distribution of tablets with customizable drug delivery profiles. Market opportunities for the Swiss Exentis Group AG in this business area are very high, according to an analysis.

Stetten - Exentis increased Group revenues by +15 percent to 11.4 million Swiss francs in the first half of 2023. There was also disproportionately strong growth in the operating result, which now stands at 2.1 million Swiss francs. The provider of a leading 3D technology platform for industrialized additive manufacturing will now turn its attention to further international growth plans.

Stetten - Exentis’ 3D technology can increase efficiency and quality in the production of ultra-fine filter structures. According to a study, one exemplary advantage of this Swiss technology is improved imaging in innovative X-ray devices.

Stetten - 3D screen printing technology from Swiss-based Exentis Group AG enables the production of more efficient motors for electric vehicles and more powerful fuel cells. With its additive manufacturing process, Exentis is a pioneer in these areas, according to a study.

Stetten - Exentis Group AG has a market potential of around 200 billion Swiss francs, according to a study. It covers three strategic business areas of Exentis' 3D technology platform for industrialized additive manufacturing.

Stetten/Boston - Exentis has appointed the business executive Eric Bert as President Exentis Americas. In this newly created position, Bert will be tasked with establishing the technology oft the Swiss company Exentis on the North American market. This involves the only 3D technology platform in the world that enables large-scale industrial production.

Stetten AG - Exentis Group AG’ 3D technology platform and strategic business units are benefiting from current megatrends. The effect increases Exentis’ long-term growth prospects, according to a study by the management consultancy Roland Berger.

Stetten/New York - The swiss 3D technology platform from Exentis is now also being used by the drug manufacturer Hovione for the industrial production of 3D printed tablets. To this end, New York-based Laxxon Medical, a licensee of Exentis, has agreed a long-term collaboration with Hovione.

Stetten AG - Exentis Group AG’s license-based business model has laid the foundations for strong growth, says a study from the consulting company Roland Berger. Exentis offers a 3D technology platform for industrialized additive manufacturing.

Stetten AG - The Exentis Group AG is focusing on further internationalization. The provider of a leading 3D technology platform for industrialized additive manufacturing is comprehensively realigning its marketing strategy, including its website.

Stetten - In the first six months of 2022, the Exentis Group has already sold more systems than in 2021 as a whole. Sales of the provider of a leading 3D technology platform based in Stetten in the canton of Aargau increased by 4 percent to 10 million Swiss francs year on year. The Group expects business to remain positive in the current half-year.